- Home
- KRYS vs SUZ Comparison
KRYS vs SUZ Comparison
Compare KRYS & SUZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | KRYS | SUZ |
|---|---|---|
| Founded | 2015 | 1924 |
| Country | United States | Brazil |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Paper |
| Sector | Health Care | Basic Materials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.6B | 10.8B |
| IPO Year | 2017 | 2002 |
Fundamental Metrics
Financial Performance| Metric | KRYS | SUZ |
|---|---|---|
| Price | $345.32 | $8.45 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 11 | 0 |
| Target Price | ★ $297.60 | N/A |
| AVG Volume (30 Days) | 242.1K | ★ 3.3M |
| Earning Date | 05-04-2026 | 05-11-2026 |
| Dividend Yield | N/A | ★ 2.15% |
| EPS Growth | ★ 128.00 | N/A |
| EPS | ★ 1.83 | N/A |
| Revenue | ★ $389,130,000.00 | N/A |
| Revenue This Year | $38.74 | $13.28 |
| Revenue Next Year | $32.53 | $13.57 |
| P/E Ratio | $186.02 | ★ $5.58 |
| Revenue Growth | ★ 33.94 | N/A |
| 52 Week Low | $130.17 | $7.92 |
| 52 Week High | $347.67 | $11.54 |
Technical Indicators
Market Signals| Indicator | KRYS | SUZ |
|---|---|---|
| Relative Strength Index (RSI) | 73.08 | 52.34 |
| Support Level | $253.89 | $8.11 |
| Resistance Level | N/A | $9.66 |
| Average True Range (ATR) | 12.58 | 0.17 |
| MACD | 3.13 | 0.07 |
| Stochastic Oscillator | 86.78 | 78.52 |
Price Performance
Historical ComparisonAbout KRYS Krystal Biotech Inc.
Krystal Biotech Inc is an integrated, commercial-stage biotechnology company focused on the discovery, development, manufacturing, and commercialization of genetic medicines to treat diseases with high unmet medical needs. The company uses its patented HSV-1-based gene therapy platform to create vectors that deliver therapeutic transgenes to target cells. It possesses exclusive rights to develop, manufacture, and commercialize VYJUVEK internationally. The company operates as one operating segment focused on pharmaceutical products and manufactures, markets, and sells VYJUVEK in the United States and markets and sells VYJUVEK in the European Union, and Japan.
About SUZ Suzano S.A.
Suzano SA produces and sells pulp and a variety of paper products. The company organizes itself into two segments based on product type: Pulp and Paper. The Pulp segment generates the majority of revenue. The firm's product portfolio includes printing and writing paper, paperboard, diapers, and sanitary napkins. The company owns forest land and plants in Brazil, where it harvests timber and turns the timber into pulp and paper in its plants.